Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease.

G M Van Rosendaal1

  • 1Division of Gastroenterology, Calgary General Hospital, Alta.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|July 15, 1989
PubMed
Summary

Treatment for inflammatory bowel disease (IBD) is expanding, with options chosen based on disease severity. Newer 5-aminosalicylic acid (5-ASA) compounds and other therapies offer improved management for ulcerative colitis and other IBD conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Issues raised by psyllium meta-analysis.

The American journal of clinical nutrition·2001
Same author

Patient outcomes related to percutaneous endoscopic gastrostomy placement.

Journal of clinical gastroenterology·2001
Same author

Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding.

The American journal of gastroenterology·2000
Same author

How are decisions made about the use of percutaneous endoscopic gastrostomy for long-term nutritional support?

The American journal of gastroenterology·1999
Same author

Difficult decisions for long-term tube-feeding.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1999
Same author

The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms.

The American journal of gastroenterology·1998

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Inflammatory bowel disease (IBD) management has evolved with numerous treatment options.
  • Sulfasalazine and corticosteroids have paved the way for novel therapeutic agents.
  • Treatment selection is guided by disease extent and severity.

Purpose of the Study:

  • To review current and emerging treatment strategies for inflammatory bowel disease.
  • To highlight the role of 5-aminosalicylic acid (5-ASA) compounds in IBD management.
  • To discuss the comprehensive management approach for IBD patients.

Main Methods:

  • Review of existing literature on IBD treatments.
  • Analysis of the efficacy of various therapeutic agents, including 5-ASA, corticosteroids, and metronidazole.
  • Discussion of adjunctive therapies such as nutritional support and surgery.

Main Results:

  • Rectal 5-ASA demonstrates significant efficacy in distal ulcerative colitis.
  • Oral 5-ASA formulations are increasingly utilized.
  • Immunosuppressive agents are valuable for chronic refractory IBD cases.
  • Nutritional therapy, surgery, and psychosocial support are integral to patient care.

Conclusions:

  • A diverse range of therapeutic options exists for IBD, tailored to individual patient needs.
  • Continued research into the etiology and pathogenesis of IBD is expected to yield further treatment innovations.
  • Multifaceted management strategies are crucial for optimizing outcomes in IBD patients.

Related Experiment Videos